论文部分内容阅读
替硝唑(Tinidazole,TNZ)是由美国Pfizer公司继甲硝唑后研制的硝基咪唑抗厌氧菌及抗原虫药[1],为甲硝唑同系物,但疗效比甲硝唑为高,耐受性更好,不良反应一般不常见。其临床主要用于各种厌氧菌感染如败血症、骨髓炎、腹腔感染、盆腔感染、肺支气管感染、鼻窦炎、皮肤蜂窝组织炎、口腔感染及术后伤口感染。2007年4月-2012年7月在我科共发生2例口服替硝唑后出现过敏反应,现报告如下。
Tinidazole (TNZ) is a nitroimidazole anti-anaerobic and anti-protozoal drug developed by the American company Pfizer following metronidazole [1], which is a metronidazole homologue, but its efficacy is higher than that of metronidazole. Sex is better, adverse reactions are not common. Its clinical is mainly used for various anaerobic infections such as sepsis, osteomyelitis, abdominal infections, pelvic infections, bronchial lung infections, sinusitis, skin cellulitis, oral infections and postoperative wound infections. April 2007 - July 2012 in our department occurred after two oral tinidazole allergic reaction, are as follows.